Contributors
Journal
Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
Title:
PLoS ONE
Publisher:
Public Library of Science
(San Francisco, USA
)
ISSN
(Electronic):
1932-6203
Publication date Collection: 2012
Publication date
(Electronic):
3
August
2012
Volume: 7
Issue: 8
Electronic Location Identifier: e41936
Affiliations
[1
]University of Rochester School of Medicine and Dentistry, Rochester, New York, United
States of America
[2
]IAVI Human Immunology Laboratory, Imperial College, London, United Kingdom
[3
]International AIDS Vaccine Initiative (IAVI), New York, New York, United States of
America
[4
]Global BioSolutions, Melbourne, Victoria, Australia
[5
]The EMMES Corporation, Rockville, Maryland, United States of America
University of Pittsburgh, United States of America
Author notes
Competing Interests: IAVI is a non-profit organization, neither IAVI nor IAVI-affiliated co-authors report
any competing interests that may interfere with the objective assessment of this manuscript
or with the ability to adhere to all PloS ONE policies on sharing data and materials.
The affiliations of Burc Barin, Kelley Loughran, and James Ackland do not alter the
authors’ ability to adhere to all the PLoS ONE policies on sharing data and materials.
Conceived and designed the experiments: JLE PF JA JC JG. Performed the experiments:
MK LH CB MH DG PH EC TTF JK HC MCC JG JC. Analyzed the data: BB MH EC JC JG JLE PF.
Contributed reagents/materials/analysis tools: ES JA KL DZ TTF LC NF. Wrote the paper:
MK JG BB EC JC PF JLE. Clinical monitoring and program management: SW WK. Medical
monitoring: SW WK. Data manager: KL. Principal Investigator at the University of Rochester
Medical Center: MK. LB
Article
Publisher ID:
PONE-D-12-09415
DOI: 10.1371/journal.pone.0041936
PMC ID: 3411704
PubMed ID: 22870265
SO-VID: 424a5bbf-8b0c-4f42-9cd1-0a376c5bfe14
Copyright statement:
Copyright @
2012
License:
This is an open-access article distributed under the terms of the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction
in any medium, provided the original author and source are credited.
History
Date
received
: 23
March
2012
Date
accepted
: 26
June
2012
Funding
This study was funded by the International AIDS Vaccine Initiative and its donors,
including the generous support of the American people through the United States Agency
for International Development (USAID; USAID Cooperative Agreement Number GPO-A-00-06-00006-00).
The contents of this manuscript are the responsibility of IAVI and do not necessarily
reflect the views of USAID or the US government. The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Categories
Subject:
Research Article
Subject:
Biology
Subject:
Immunology
Subject:
Immune Cells
Subject:
T Cells
Subject:
Immunologic Techniques
Subject:
Immunoassays
Subject:
Antigen Processing and Recognition
Subject:
Immune Response
Subject:
Immunity
Subject:
Microbiology
Subject:
Virology
Subject:
Viral Vaccines
Subject:
Molecular Cell Biology
Subject:
Cytometry
Subject:
Flow Cytometry
Subject:
Medicine
Subject:
Anatomy and Physiology
Subject:
Immune Physiology
Subject:
Antibodies
Subject:
Clinical Immunology
Subject:
Immune Cells
Subject:
T Cells
Subject:
Immunity
Subject:
Vaccination
Subject:
Vaccine Development
Subject:
Immune Activation
Subject:
Immunity to Infections
Subject:
Immunizations
Subject:
Immune Response
Subject:
Immunologic Techniques
Subject:
Clinical Research Design
Subject:
Clinical Trials
Subject:
Phase I
Subject:
Diagnostic Medicine
Subject:
Clinical Laboratory Sciences
Subject:
Clinical Immunology
Subject:
Drugs and Devices
Subject:
Adverse Reactions
Subject:
Infectious Diseases
Subject:
Viral Diseases
Subject:
HIV
Subject:
HIV prevention
Subject:
Retrovirology and HIV immunopathogenesis
Subject:
Public Health
Subject:
Immunizations